Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperdal Consta Switching Study in Schizophrenia
NCT01726335Phase 4Completed
- Sponsor
- Janssen-Cilag
- Start
- Jan 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in schizophrenia, sponsored by Janssen-Cilag. Started Jan 2006; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01726335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01726335.